These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 24156026)

  • 1. The changing face of thyroid cancer in a population-based cohort.
    Pathak KA; Leslie WD; Klonisch TC; Nason RW
    Cancer Med; 2013 Aug; 2(4):537-44. PubMed ID: 24156026
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identifying the most appropriate age threshold for TNM stage grouping of well-differentiated thyroid cancer.
    Hendrickson-Rebizant J; Sigvaldason H; Nason RW; Pathak KA
    Eur J Surg Oncol; 2015 Aug; 41(8):1028-32. PubMed ID: 25986855
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic significance of extranodal extension of regional lymph node metastasis in papillary thyroid cancer.
    Wu MH; Shen WT; Gosnell J; Duh QY
    Head Neck; 2015 Sep; 37(9):1336-43. PubMed ID: 24821456
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recent trends in the incidence, geographical distribution, and survival from thyroid cancer in Wales, 1985-2010.
    Amphlett B; Lawson Z; Abdulrahman GO; White C; Bailey R; Premawardhana LD; Okosieme OE
    Thyroid; 2013 Nov; 23(11):1470-8. PubMed ID: 23488941
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic nomograms to predict oncological outcome of thyroid cancers.
    Pathak KA; Mazurat A; Lambert P; Klonisch T; Nason RW
    J Clin Endocrinol Metab; 2013 Dec; 98(12):4768-75. PubMed ID: 24152685
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Age greater than 60 years portends a worse prognosis in patients with papillary thyroid cancer: should there be three age categories for staging?
    Kauffmann RM; Hamner JB; Ituarte PHG; Yim JH
    BMC Cancer; 2018 Mar; 18(1):316. PubMed ID: 29566662
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Thyroid cancer incidence trends by histology in 25 countries: a population-based study.
    Miranda-Filho A; Lortet-Tieulent J; Bray F; Cao B; Franceschi S; Vaccarella S; Dal Maso L
    Lancet Diabetes Endocrinol; 2021 Apr; 9(4):225-234. PubMed ID: 33662333
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Changing trends in incidence and mortality of thyroid cancer in Scotland.
    Reynolds RM; Weir J; Stockton DL; Brewster DH; Sandeep TC; Strachan MW
    Clin Endocrinol (Oxf); 2005 Feb; 62(2):156-62. PubMed ID: 15670190
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The age factor in survival of a population cohort of well-differentiated thyroid cancer.
    Mazurat A; Torroni A; Hendrickson-Rebizant J; Benning H; Nason RW; Pathak KA
    Endocr Connect; 2013; 2(3):154-60. PubMed ID: 24008393
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic indicators in well-differentiated thyroid carcinoma when controlling for stage and treatment.
    Krook KA; Fedewa SA; Chen AY
    Laryngoscope; 2015 Apr; 125(4):1021-7. PubMed ID: 25583017
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increasing incidence of thyroid cancer in the United States, 1973-2002.
    Davies L; Welch HG
    JAMA; 2006 May; 295(18):2164-7. PubMed ID: 16684987
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A birth cohort analysis of the incidence of papillary thyroid cancer in the United States, 1973-2004.
    Zhu C; Zheng T; Kilfoy BA; Han X; Ma S; Ba Y; Bai Y; Wang R; Zhu Y; Zhang Y
    Thyroid; 2009 Oct; 19(10):1061-6. PubMed ID: 19732011
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Survival in Differentiated Thyroid Cancer: Comparing the AJCC Cancer Staging Seventh and Eighth Editions.
    Tam S; Boonsripitayanon M; Amit M; Fellman BM; Li Y; Busaidy NL; Cabanillas ME; Dadu R; Sherman S; Waguespack SG; Williams MD; Goepfert RP; Gross ND; Perrier ND; Sturgis EM; Zafereo ME
    Thyroid; 2018 Oct; 28(10):1301-1310. PubMed ID: 30141373
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rising Incidence and Incidence-Based Mortality of Thyroid Cancer in California, 2000-2017.
    Yan KL; Li S; Tseng CH; Kim J; Nguyen DT; Dawood NB; Livhits MJ; Yeh MW; Leung AM
    J Clin Endocrinol Metab; 2020 Jun; 105(6):. PubMed ID: 32166320
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased incidence of thyroid cancer in Navarra (Spain). Evolution and clinical characteristics, 1986-2010.
    Rojo Álvaro J; Bermejo Fraile B; Menéndez Torre E; Ardanaz E; Guevara M; Anda Apiñániz E
    Endocrinol Diabetes Nutr; 2017; 64(6):303-309. PubMed ID: 28604340
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pathological tumor-node-metastasis (pTNM) staging for papillary and follicular thyroid carcinomas: a retrospective analysis of 700 patients.
    Loh KC; Greenspan FS; Gee L; Miller TR; Yeo PP
    J Clin Endocrinol Metab; 1997 Nov; 82(11):3553-62. PubMed ID: 9360506
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Risk of thyroid cancer in first-degree relatives of patients with non-medullary thyroid cancer by histology type and age at diagnosis: a joint study from five Nordic countries.
    Fallah M; Pukkala E; Tryggvadottir L; Olsen JH; Tretli S; Sundquist K; Hemminki K
    J Med Genet; 2013 Jun; 50(6):373-82. PubMed ID: 23585692
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Trends in thyroid cancer: Retrospective analysis of incidence and survival in Denmark 1980-2014.
    Mirian C; Grønhøj C; Jensen DH; Jakobsen KK; Karnov K; Jensen JS; Hahn CH; Klitmøller TA; Bentzen J; von Buchwald C
    Cancer Epidemiol; 2018 Aug; 55():81-87. PubMed ID: 29852396
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Italian cancer figures--Report 2015: The burden of rare cancers in Italy.
    ; Busco S; Buzzoni C; Mallone S; Trama A; Castaing M; Bella F; Amodio R; Bizzoco S; Cassetti T; Cirilli C; Cusimano R; De Angelis R; Fusco M; Gatta G; Gennaro V; Giacomin A; Giorgi Rossi P; Mangone L; Mannino S; Rossi S; Pierannunzio D; Tavilla A; Tognazzo S; Tumino R; Vicentini M; Vitale MF; Crocetti E; Dal Maso L
    Epidemiol Prev; 2016; 40(1 Suppl 2):1-120. PubMed ID: 26951748
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The impact of age and gender on papillary thyroid cancer survival.
    Jonklaas J; Nogueras-Gonzalez G; Munsell M; Litofsky D; Ain KB; Bigos ST; Brierley JD; Cooper DS; Haugen BR; Ladenson PW; Magner J; Robbins J; Ross DS; Skarulis MC; Steward DL; Maxon HR; Sherman SI;
    J Clin Endocrinol Metab; 2012 Jun; 97(6):E878-87. PubMed ID: 22496497
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.